laceran 5 mg comprimate
sun pharmaceutical industries, ltd - ramiprilum - comprimate - 5 mg
faringosept 10 mg comprimate de supt
sun pharmaceutical industries, ltd - ambazonum - comprimate de supt - 10 mg
faringosept lămâie 10 mg comprimate de supt
sun pharmaceutical industries, ltd - ambazonum - comprimate de supt - 10 mg
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
faringosept comprimate de supt 10 mg
sun pharmaceutical industries ltd - ambazonum - comprimate de supt - 10 mg
faringosept lamaie comprimate de supt 10 mg
sun pharmaceutical industries ltd - ambazonum - comprimate de supt - 10 mg
synerpen 500 mg + 500 mg pulbere pentru soluţie perfuzabilă
sun pharmaceutical industries, ltd - imipenemum + cilastatinum - pulbere pentru soluţie perfuzabilă - 500 mg + 500 mg
medabon 200 mg + 0,2 mg comprimate + comprimate vaginale
sun pharmaceutical industries ltd. - mifepristonum + misoprostolum - comprimate + comprimate vaginale - 200 mg + 0,2 mg
bortezomib sun 3,5 mg
sun pharmaceutical industries europe b.v. - olanda - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
ertapenem sun 1 g
sun pharmaceutical industries europe b.v. - olanda - ertapenemum - pulb. pt. conc. pt. sol. perf. - 1g - alte antibiotice betalactamice carbapeneme